Fenestrated endovascular aneurysm repair yielded a median survival of 6.9 years and 10-year aneurysm-related mortality of 6.7%, with an 8-year cumulative re-intervention rate of 27.7%.
What are the long-term outcomes and durability of fenestrated endovascular aneurysm repair (FEVAR) in patients with aneurysmal pathology?
1,587 patients with aneurysmal pathology from 15 UK centres, median age 75 years, 87.9% male.
Custom-made fenestrated endovascular aneurysm repair (FEVAR) alone
All-cause survival, aneurysm-related mortality, and re-interventionhard clinical
FEVAR demonstrates acceptable long-term survival and low aneurysm-related mortality, though it carries a significant risk of re-intervention primarily due to graft-related complications, necessitating long-term surveillance.
Absolute Event Rate: 0% vs 0%
Abstract Introduction GLOBALSTAR is a registry of 1587 FEVAR cases from 15 UK centres (2003–2022), established by BSET. Aims were to report long-term outcomes for FEVAR. Methods Study design: retrospective cohort study of GLOBALSTAR. Inclusion criteria: aneurysmal pathology and custom-made FEVAR alone. Data were collected according to a standardised protocol. Time-to-event analyses were conducted for all-cause survival, aneurysm-related mortality and re-intervention. Log-rank sub-analyses were conducted for octogenarians and sexes. Results 1587 patients across 15 centres were included. Median age = 75 years 69–79,IQR and male = 87.9%. Patients were co-morbid with 45.0% IHD and 73.3% hypertension. All-cause survival at 3, 5 and 10 years was 79.5% 95% c.i., 77.6–81.6%, 64.2% 61.8–66.7% and 30.3% 27.4–33.4% with median survival = 6.9 years 6.6–7.2. Aneurysm-related mortality cumulative incidence = 6.7% at 10 years 5.4–8.1%. Secondary sac rupture was rare with 4.0 events/1000 patient-years. Cumulative incidence of re-intervention at 3, 5 and 8 years was 20.2% 18.2–22.3%, 24.4% 22.2–26.7% and 27.7% 25.3–30.2%. Graft-related complications accounted for 73.8% of re-interventions. Women had significantly worse 2-year survival (80.4%, 75.0- 86.3%) than men (86.4%, 84.6–88.3%) (P 0.05), driven by peri-operative mortality. Beyond 2 years, differences in survival were not significant. Octogenarians had equivalent survival (89.6% 86.5–92.7%) to non-octogenarians (92.2% 90.7–93.7%) up to 1 year (P = 0.098). Beyond 1 year, survival differences were significant. Octogenarians' median survival = 5.4 years 5.0–6.1. Conclusions Long-term outcomes for FEVAR appear acceptable, with low rates of secondary sac rupture. FEVAR carries risk, especially of re-intervention- driven by graft-related complications, highlighting the importance of surveillance. Peri-operative mortality was significantly higher in women, warranting further investigation.
Building similarity graph...
Analyzing shared references across papers
Loading...
Aurélien Guéroult
St George's, University of London
British journal of surgery
St George's, University of London
St George's Hospital
BMT Group (United Kingdom)
Building similarity graph...
Analyzing shared references across papers
Loading...
Aurélien Guéroult (Sun,) reported a other. Fenestrated endovascular aneurysm repair yielded a median survival of 6.9 years and 10-year aneurysm-related mortality of 6.7%, with an 8-year cumulative re-intervention rate of 27.7%.
synapsesocial.com/papers/69c8c2d1de0f0f753b39d386 — DOI: https://doi.org/10.1093/bjs/znag018.208
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: